Skip to content
value.today
Legend Biotech Corp logo

Legend Biotech Corp

🇺🇸 Somerset, New Jersey, USABiotechnologyFounded 2015
Total raised
$150 M
1 round on record
Latest round
$150 M
Mar 2020
First round on record
Mar 2020
Today
Went public
See the company page

Legend Biotech Corp is listed today as Legend Biotech Corporation: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Legend Biotech Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2023$200 MPrivate placement after listing$50 to $250 million

Legend Biotech Corp: Private sale, Apr 2023

Investors in this round

1 investor had bought by the notice of Apr 28, 2023: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$200 M of $200 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Cayman Islands

People named in the notice

  • Lori Macomber · Executive Officer
  • Ying Huang, Ph.D. · Executive Officer, Director
  • Corazon D. Sanders, Ph.D. · Director
  • Darren Xiaohui Ji, M.D., Ph.D. · Director
  • Fangliang Zhang, Ph.D. · Director
  • Li Wai Man Mao, MD · Director
  • Li Zhu, Ph.D. · Director
  • Patrick Wai Man Casey, Ph.D. · Director
  • Philip Wai Man Yau, CPA · Director
  • Tomas Wai Man Heyman · Director
  • Ye Wang, M.S. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The exact Total Offering Amount and Total Amount Sold is US$200,000,004.16, respectively, each rounded to $200,000,005 for purposes of reporting on Form D.”

Signed by Lori Macomber, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 28, 2023. Read the notice at the SEC.

equitySEC
Mar 2020$150 MNo. 1$50 to $250 million

Legend Biotech Corp: Raise no. 1, Mar 2020

Investors in this round

8 investors had bought by the notice of Apr 7, 2020: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$150 M of $160 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Cayman Islands

People named in the notice

  • Ying Huang, Ph.D. · Executive Officer
  • Yuan Xu, Ph.D. · Executive Officer, Director
  • Fangliang Zhang, Ph.D. · Director
  • Ye Wang, M.S. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Yuan Xu, Ph.D., Ceo. Source: SEC Form D, newest notice filed Apr 7, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Legend Biotech Corp chose not to state its revenue in its newest notice of a funding round (Apr 2023).

    SEC Form D · Apr 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2023

That is all the official record says: Legend Biotech Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Legend Biotech Corp are on record.

Investors#

No investor of Legend Biotech Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 8 investors.

Largest shareholders today

Institutions holding Legend Biotech Corporation shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Legend Biotech Corp
NameRoleNamed in
Lori MacomberExecutive officerApr 2023
Ying Huang, Ph.D.Executive officerApr 2023
Yuan Xu, Ph.D.Executive officerApr 2020
Corazon D. Sanders, Ph.D.DirectorApr 2023
Darren Xiaohui Ji, M.D., Ph.D.DirectorApr 2023
Fangliang Zhang, Ph.D.DirectorApr 2023
Li Wai Man Mao, MDDirectorApr 2023
Li Zhu, Ph.D.DirectorApr 2023
Patrick Wai Man Casey, Ph.D.DirectorApr 2023
Philip Wai Man Yau, CPADirectorApr 2023
Tomas Wai Man HeymanDirectorApr 2023
Ye Wang, M.S.DirectorApr 2023
Ying Huang, Ph.D.DirectorApr 2023
Yuan Xu, Ph.D.DirectorApr 2020

Went public since 2020. Its SEC number is that of a company listed on a stock exchange.